The global market for Human Fibrinogen was estimated to be worth US$ 795.8 million in 2023 and is forecast to a readjusted size of US$ 2207 million by 2030 with a CAGR of 15.5% during the forecast period 2024-2030

Human Fibrinogen - Market

Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Human Fibrinogen is used as a medicine for blood disease. Human Fibrinogen is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer’s products are justly used in local region or countries.

Global Human Fibrinogen key players include CSL Behring, LFB Group, Shanghai RAAS Blood Products, Jiangxi Boya Bio-Pharmaceutical, GREEN CROSS, etc. Global top five manufacturers hold a share about 90%. Asia-Pacific is the largest consumption market, with a share about 60%, followed by Americas and Europe, total have a share over 30 percent. In terms of product, Human Fibrinogen Concentrate is the largest segment, with a share over 99%. And in terms of application, the largest application is Surgical Procedures.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Fibrinogen, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Human Fibrinogen by region & country, by Type, and by Application.

The Human Fibrinogen market size, estimations, and forecasts are provided in terms of sales volume (Kg) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Fibrinogen.

Market Segmentation

Scope of Human Fibrinogen - Market Report

Report Metric	Details
Report Name	Human Fibrinogen - Market
Forecasted market size in 2030	US$ 2207 million
CAGR	15.5%
Forecasted years	2024 - 2030
Segment by Type:	Human Fibrinogen Concentrate Animal Fibrinogen Concentrate
Segment by Application	Congenital Fibrinogen Deficiency Surgical Procedures
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	CSL Behring, LFB Group, Shanghai RAAS Blood Products, Jiangxi Boya Bio-Pharmaceutical, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, GREEN CROSS, Shanghai XinXing Medical, Octapharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Human Fibrinogen manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Human Fibrinogen in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Human Fibrinogen in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Human Fibrinogen - Market size in 2030?

Ans: The Human Fibrinogen - Market size in 2030 will be US$ 2207 million.

What is the market share of major companies in Human Fibrinogen - Market?

Ans: Global top five manufacturers hold a share about 90%.

What is the Human Fibrinogen - Market share by type?

Ans: In terms of product, Human Fibrinogen Concentrate is the largest segment, with a share over 99%.

Who are the main players in the Human Fibrinogen - Market report?

Ans: The main players in the Human Fibrinogen - Market are CSL Behring, LFB Group, Shanghai RAAS Blood Products, Jiangxi Boya Bio-Pharmaceutical, Hualan Biological Engineering, Harbin Pacific Biopharmaceutical, GREEN CROSS, Shanghai XinXing Medical, Octapharma

What are the Application segmentation covered in the Human Fibrinogen - Market report?

Ans: The Applications covered in the Human Fibrinogen - Market report are Congenital Fibrinogen Deficiency, Surgical Procedures

What are the Type segmentation covered in the Human Fibrinogen - Market report?

Ans: The Types covered in the Human Fibrinogen - Market report are Human Fibrinogen Concentrate, Animal Fibrinogen Concentrate

1 Market Overview

1.1 Human Fibrinogen Product Introduction

1.2 Global Human Fibrinogen Market Size Forecast

1.2.1 Global Human Fibrinogen Sales Value (2019-2030)

1.2.2 Global Human Fibrinogen Sales Volume (2019-2030)

1.2.3 Global Human Fibrinogen Sales Price (2019-2030)

1.3 Human Fibrinogen Market Trends & Drivers

1.3.1 Human Fibrinogen Industry Trends

1.3.2 Human Fibrinogen Market Drivers & Opportunity

1.3.3 Human Fibrinogen Market Challenges

1.3.4 Human Fibrinogen Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Human Fibrinogen Players Revenue Ranking (2023)

2.2 Global Human Fibrinogen Revenue by Company (2019-2024)

2.3 Global Human Fibrinogen Players Sales Volume Ranking (2023)

2.4 Global Human Fibrinogen Sales Volume by Company Players (2019-2024)

2.5 Global Human Fibrinogen Average Price by Company (2019-2024)

2.6 Key Manufacturers Human Fibrinogen Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Human Fibrinogen Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Human Fibrinogen

2.9 Human Fibrinogen Market Competitive Analysis

2.9.1 Human Fibrinogen Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Human Fibrinogen Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Fibrinogen as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Human Fibrinogen Concentrate

3.1.2 Animal Fibrinogen Concentrate

3.2 Global Human Fibrinogen Sales Value by Type

3.2.1 Global Human Fibrinogen Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Human Fibrinogen Sales Value, by Type (2019-2030)

3.2.3 Global Human Fibrinogen Sales Value, by Type (%) (2019-2030)

3.3 Global Human Fibrinogen Sales Volume by Type

3.3.1 Global Human Fibrinogen Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Human Fibrinogen Sales Volume, by Type (2019-2030)

3.3.3 Global Human Fibrinogen Sales Volume, by Type (%) (2019-2030)

3.4 Global Human Fibrinogen Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Congenital Fibrinogen Deficiency

4.1.2 Surgical Procedures

4.2 Global Human Fibrinogen Sales Value by Application

4.2.1 Global Human Fibrinogen Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Human Fibrinogen Sales Value, by Application (2019-2030)

4.2.3 Global Human Fibrinogen Sales Value, by Application (%) (2019-2030)

4.3 Global Human Fibrinogen Sales Volume by Application

4.3.1 Global Human Fibrinogen Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Human Fibrinogen Sales Volume, by Application (2019-2030)

4.3.3 Global Human Fibrinogen Sales Volume, by Application (%) (2019-2030)

4.4 Global Human Fibrinogen Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Human Fibrinogen Sales Value by Region

5.1.1 Global Human Fibrinogen Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Human Fibrinogen Sales Value by Region (2019-2024)

5.1.3 Global Human Fibrinogen Sales Value by Region (2025-2030)

5.1.4 Global Human Fibrinogen Sales Value by Region (%), (2019-2030)

5.2 Global Human Fibrinogen Sales Volume by Region

5.2.1 Global Human Fibrinogen Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Human Fibrinogen Sales Volume by Region (2019-2024)

5.2.3 Global Human Fibrinogen Sales Volume by Region (2025-2030)

5.2.4 Global Human Fibrinogen Sales Volume by Region (%), (2019-2030)

5.3 Global Human Fibrinogen Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Human Fibrinogen Sales Value, 2019-2030

5.4.2 North America Human Fibrinogen Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Human Fibrinogen Sales Value, 2019-2030

5.5.2 Europe Human Fibrinogen Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Human Fibrinogen Sales Value, 2019-2030

5.6.2 Asia Pacific Human Fibrinogen Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Human Fibrinogen Sales Value, 2019-2030

5.7.2 South America Human Fibrinogen Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Human Fibrinogen Sales Value, 2019-2030

5.8.2 Middle East & Africa Human Fibrinogen Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Human Fibrinogen Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Human Fibrinogen Sales Value

6.2.1 Key Countries/Regions Human Fibrinogen Sales Value, 2019-2030

6.2.2 Key Countries/Regions Human Fibrinogen Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Human Fibrinogen Sales Value, 2019-2030

6.3.2 United States Human Fibrinogen Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Human Fibrinogen Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Human Fibrinogen Sales Value, 2019-2030

6.4.2 Europe Human Fibrinogen Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Human Fibrinogen Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Human Fibrinogen Sales Value, 2019-2030

6.5.2 China Human Fibrinogen Sales Value by Type (%), 2023 VS 2030

6.5.3 China Human Fibrinogen Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Human Fibrinogen Sales Value, 2019-2030

6.6.2 Japan Human Fibrinogen Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Human Fibrinogen Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Human Fibrinogen Sales Value, 2019-2030

6.7.2 South Korea Human Fibrinogen Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Human Fibrinogen Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Human Fibrinogen Sales Value, 2019-2030

6.8.2 Southeast Asia Human Fibrinogen Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Human Fibrinogen Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Human Fibrinogen Sales Value, 2019-2030

6.9.2 India Human Fibrinogen Sales Value by Type (%), 2023 VS 2030

6.9.3 India Human Fibrinogen Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 CSL Behring

7.1.1 CSL Behring Company Information

7.1.2 CSL Behring Introduction and Business Overview

7.1.3 CSL Behring Human Fibrinogen Sales, Revenue and Gross Margin (2019-2024)

7.1.4 CSL Behring Human Fibrinogen Product Offerings

7.1.5 CSL Behring Recent Development

7.2 LFB Group

7.2.1 LFB Group Company Information

7.2.2 LFB Group Introduction and Business Overview

7.2.3 LFB Group Human Fibrinogen Sales, Revenue and Gross Margin (2019-2024)

7.2.4 LFB Group Human Fibrinogen Product Offerings

7.2.5 LFB Group Recent Development

7.3 Shanghai RAAS Blood Products

7.3.1 Shanghai RAAS Blood Products Company Information

7.3.2 Shanghai RAAS Blood Products Introduction and Business Overview

7.3.3 Shanghai RAAS Blood Products Human Fibrinogen Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Shanghai RAAS Blood Products Human Fibrinogen Product Offerings

7.3.5 Shanghai RAAS Blood Products Recent Development

7.4 Jiangxi Boya Bio-Pharmaceutical

7.4.1 Jiangxi Boya Bio-Pharmaceutical Company Information

7.4.2 Jiangxi Boya Bio-Pharmaceutical Introduction and Business Overview

7.4.3 Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Product Offerings

7.4.5 Jiangxi Boya Bio-Pharmaceutical Recent Development

7.5 Hualan Biological Engineering

7.5.1 Hualan Biological Engineering Company Information

7.5.2 Hualan Biological Engineering Introduction and Business Overview

7.5.3 Hualan Biological Engineering Human Fibrinogen Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Hualan Biological Engineering Human Fibrinogen Product Offerings

7.5.5 Hualan Biological Engineering Recent Development

7.6 Harbin Pacific Biopharmaceutical

7.6.1 Harbin Pacific Biopharmaceutical Company Information

7.6.2 Harbin Pacific Biopharmaceutical Introduction and Business Overview

7.6.3 Harbin Pacific Biopharmaceutical Human Fibrinogen Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Harbin Pacific Biopharmaceutical Human Fibrinogen Product Offerings

7.6.5 Harbin Pacific Biopharmaceutical Recent Development

7.7 GREEN CROSS

7.7.1 GREEN CROSS Company Information

7.7.2 GREEN CROSS Introduction and Business Overview

7.7.3 GREEN CROSS Human Fibrinogen Sales, Revenue and Gross Margin (2019-2024)

7.7.4 GREEN CROSS Human Fibrinogen Product Offerings

7.7.5 GREEN CROSS Recent Development

7.8 Shanghai XinXing Medical

7.8.1 Shanghai XinXing Medical Company Information

7.8.2 Shanghai XinXing Medical Introduction and Business Overview

7.8.3 Shanghai XinXing Medical Human Fibrinogen Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Shanghai XinXing Medical Human Fibrinogen Product Offerings

7.8.5 Shanghai XinXing Medical Recent Development

7.9 Octapharma

7.9.1 Octapharma Company Information

7.9.2 Octapharma Introduction and Business Overview

7.9.3 Octapharma Human Fibrinogen Sales, Revenue and Gross Margin (2019-2024)

7.9.4 Octapharma Human Fibrinogen Product Offerings

7.9.5 Octapharma Recent Development

8 Industry Chain Analysis

8.1 Human Fibrinogen Industrial Chain

8.2 Human Fibrinogen Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Human Fibrinogen Sales Model

8.5.2 Sales Channel

8.5.3 Human Fibrinogen Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

CSL Behring

Hualan Biological Engineering

Harbin Pacific Biopharmaceutical

Shanghai XinXing Medical

Shanghai RAAS Blood Products

Jiangxi Boya Bio-Pharmaceutical

Green Cross

Octapharma AG

LFB Group

List of Tables

Table 1. Human Fibrinogen Market Trends

Table 2. Human Fibrinogen Market Drivers & Opportunity

Table 3. Human Fibrinogen Market Challenges

Table 4. Human Fibrinogen Market Restraints

Table 5. Global Human Fibrinogen Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Human Fibrinogen Revenue Market Share by Company (2019-2024)

Table 7. Global Human Fibrinogen Sales Volume by Company (2019-2024) & (Kg)

Table 8. Global Human Fibrinogen Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Human Fibrinogen Price by Company (2019-2024) & (USD/Kg)

Table 10. Key Manufacturers Human Fibrinogen Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Human Fibrinogen Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Human Fibrinogen

Table 13. Global Human Fibrinogen Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Fibrinogen as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Human Fibrinogen Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Human Fibrinogen Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Human Fibrinogen Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Human Fibrinogen Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Human Fibrinogen Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Human Fibrinogen Sales Volume by Type: 2019 VS 2023 VS 2030 (Kg)

Table 22. Global Human Fibrinogen Sales Volume by Type (2019-2024) & (Kg)

Table 23. Global Human Fibrinogen Sales Volume by Type (2025-2030) & (Kg)

Table 24. Global Human Fibrinogen Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Human Fibrinogen Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Human Fibrinogen Price by Type (2019-2024) & (USD/Kg)

Table 27. Global Human Fibrinogen Price by Type (2025-2030) & (USD/Kg)

Table 28. Global Human Fibrinogen Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Human Fibrinogen Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Human Fibrinogen Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Human Fibrinogen Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Human Fibrinogen Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Human Fibrinogen Sales Volume by Application: 2019 VS 2023 VS 2030 (Kg)

Table 34. Global Human Fibrinogen Sales Volume by Application (2019-2024) & (Kg)

Table 35. Global Human Fibrinogen Sales Volume by Application (2025-2030) & (Kg)

Table 36. Global Human Fibrinogen Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Human Fibrinogen Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Human Fibrinogen Price by Application (2019-2024) & (USD/Kg)

Table 39. Global Human Fibrinogen Price by Application (2025-2030) & (USD/Kg)

Table 40. Global Human Fibrinogen Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Human Fibrinogen Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Human Fibrinogen Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Human Fibrinogen Sales Value by Region (2019-2024) & (%)

Table 44. Global Human Fibrinogen Sales Value by Region (2025-2030) & (%)

Table 45. Global Human Fibrinogen Sales Volume by Region (Kg): 2019 VS 2023 VS 2030

Table 46. Global Human Fibrinogen Sales Volume by Region (2019-2024) & (Kg)

Table 47. Global Human Fibrinogen Sales Volume by Region (2025-2030) & (Kg)

Table 48. Global Human Fibrinogen Sales Volume by Region (2019-2024) & (%)

Table 49. Global Human Fibrinogen Sales Volume by Region (2025-2030) & (%)

Table 50. Global Human Fibrinogen Average Price by Region (2019-2024) & (USD/Kg)

Table 51. Global Human Fibrinogen Average Price by Region (2025-2030) & (USD/Kg)

Table 52. Key Countries/Regions Human Fibrinogen Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Human Fibrinogen Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Human Fibrinogen Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Human Fibrinogen Sales Volume, (2019-2024) & (Kg)

Table 56. Key Countries/Regions Human Fibrinogen Sales Volume, (2025-2030) & (Kg)

Table 57. CSL Behring Company Information

Table 58. CSL Behring Introduction and Business Overview

Table 59. CSL Behring Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 60. CSL Behring Human Fibrinogen Product Offerings

Table 61. CSL Behring Recent Development

Table 62. LFB Group Company Information

Table 63. LFB Group Introduction and Business Overview

Table 64. LFB Group Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 65. LFB Group Human Fibrinogen Product Offerings

Table 66. LFB Group Recent Development

Table 67. Shanghai RAAS Blood Products Company Information

Table 68. Shanghai RAAS Blood Products Introduction and Business Overview

Table 69. Shanghai RAAS Blood Products Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 70. Shanghai RAAS Blood Products Human Fibrinogen Product Offerings

Table 71. Shanghai RAAS Blood Products Recent Development

Table 72. Jiangxi Boya Bio-Pharmaceutical Company Information

Table 73. Jiangxi Boya Bio-Pharmaceutical Introduction and Business Overview

Table 74. Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 75. Jiangxi Boya Bio-Pharmaceutical Human Fibrinogen Product Offerings

Table 76. Jiangxi Boya Bio-Pharmaceutical Recent Development

Table 77. Hualan Biological Engineering Company Information

Table 78. Hualan Biological Engineering Introduction and Business Overview

Table 79. Hualan Biological Engineering Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 80. Hualan Biological Engineering Human Fibrinogen Product Offerings

Table 81. Hualan Biological Engineering Recent Development

Table 82. Harbin Pacific Biopharmaceutical Company Information

Table 83. Harbin Pacific Biopharmaceutical Introduction and Business Overview

Table 84. Harbin Pacific Biopharmaceutical Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 85. Harbin Pacific Biopharmaceutical Human Fibrinogen Product Offerings

Table 86. Harbin Pacific Biopharmaceutical Recent Development

Table 87. GREEN CROSS Company Information

Table 88. GREEN CROSS Introduction and Business Overview

Table 89. GREEN CROSS Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 90. GREEN CROSS Human Fibrinogen Product Offerings

Table 91. GREEN CROSS Recent Development

Table 92. Shanghai XinXing Medical Company Information

Table 93. Shanghai XinXing Medical Introduction and Business Overview

Table 94. Shanghai XinXing Medical Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 95. Shanghai XinXing Medical Human Fibrinogen Product Offerings

Table 96. Shanghai XinXing Medical Recent Development

Table 97. Octapharma Company Information

Table 98. Octapharma Introduction and Business Overview

Table 99. Octapharma Human Fibrinogen Sales (Kg), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2019-2024)

Table 100. Octapharma Human Fibrinogen Product Offerings

Table 101. Octapharma Recent Development

Table 102. Key Raw Materials Lists

Table 103. Raw Materials Key Suppliers Lists

Table 104. Human Fibrinogen Downstream Customers

Table 105. Human Fibrinogen Distributors List

Table 106. Research Programs/Design for This Report

Table 107. Key Data Information from Secondary Sources

Table 108. Key Data Information from Primary Sources

List of Figures

Figure 1. Human Fibrinogen Product Picture

Figure 2. Global Human Fibrinogen Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Human Fibrinogen Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Human Fibrinogen Sales Volume (2019-2030) & (Kg)

Figure 5. Global Human Fibrinogen Sales Price (2019-2030) & (USD/Kg)

Figure 6. Human Fibrinogen Report Years Considered

Figure 7. Global Human Fibrinogen Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Human Fibrinogen Players Sales Volume Ranking (2023) & (Kg)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Fibrinogen Revenue in 2023

Figure 10. Human Fibrinogen Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Human Fibrinogen Concentrate Picture

Figure 12. Animal Fibrinogen Concentrate Picture

Figure 13. Global Human Fibrinogen Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Human Fibrinogen Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Human Fibrinogen Sales Volume by Type (2019 VS 2023 VS 2030) & (Kg)

Figure 16. Global Human Fibrinogen Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Human Fibrinogen Price by Type (2019-2030) & (USD/Kg)

Figure 18. Product Picture of Congenital Fibrinogen Deficiency

Figure 19. Product Picture of Surgical Procedures

Figure 20. Global Human Fibrinogen Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Human Fibrinogen Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Human Fibrinogen Sales Volume by Application (2019 VS 2023 VS 2030) & (Kg)

Figure 23. Global Human Fibrinogen Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Human Fibrinogen Price by Application (2019-2030) & (USD/Kg)

Figure 25. North America Human Fibrinogen Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Human Fibrinogen Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Human Fibrinogen Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Human Fibrinogen Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Human Fibrinogen Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Human Fibrinogen Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Human Fibrinogen Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Human Fibrinogen Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Human Fibrinogen Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Human Fibrinogen Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Human Fibrinogen Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Human Fibrinogen Sales Volume (%), (2019-2030)

Figure 37. United States Human Fibrinogen Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Human Fibrinogen Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Human Fibrinogen Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Human Fibrinogen Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Human Fibrinogen Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Human Fibrinogen Sales Value by Application (%), 2023 VS 2030

Figure 43. China Human Fibrinogen Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Human Fibrinogen Sales Value by Type (%), 2023 VS 2030

Figure 45. China Human Fibrinogen Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Human Fibrinogen Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Human Fibrinogen Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Human Fibrinogen Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Human Fibrinogen Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Human Fibrinogen Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Human Fibrinogen Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Human Fibrinogen Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Human Fibrinogen Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Human Fibrinogen Sales Value by Application (%), 2023 VS 2030

Figure 55. India Human Fibrinogen Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Human Fibrinogen Sales Value by Type (%), 2023 VS 2030

Figure 57. India Human Fibrinogen Sales Value by Application (%), 2023 VS 2030

Figure 58. Human Fibrinogen Industrial Chain

Figure 59. Human Fibrinogen Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions